81 related articles for article (PubMed ID: 35529783)
61. Metabolic Reprogramming in Brain Tumors.
Venneti S; Thompson CB
Annu Rev Pathol; 2017 Jan; 12():515-545. PubMed ID: 28068482
[TBL] [Abstract][Full Text] [Related]
62. Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA).
Sperduto PW; Yang TJ; Beal K; Pan H; Brown PD; Bangdiwala A; Shanley R; Yeh N; Gaspar LE; Braunstein S; Sneed P; Boyle J; Kirkpatrick JP; Mak KS; Shih HA; Engelman A; Roberge D; Arvold ND; Alexander B; Awad MM; Contessa J; Chiang V; Hardie J; Ma D; Lou E; Sperduto W; Mehta MP
JAMA Oncol; 2017 Jun; 3(6):827-831. PubMed ID: 27892978
[TBL] [Abstract][Full Text] [Related]
63. Circadian clocks and breast cancer.
Blakeman V; Williams JL; Meng QJ; Streuli CH
Breast Cancer Res; 2016 Sep; 18(1):89. PubMed ID: 27590298
[TBL] [Abstract][Full Text] [Related]
64. Circadian Rhythm Disruption Promotes Lung Tumorigenesis.
Papagiannakopoulos T; Bauer MR; Davidson SM; Heimann M; Subbaraj L; Bhutkar A; Bartlebaugh J; Vander Heiden MG; Jacks T
Cell Metab; 2016 Aug; 24(2):324-31. PubMed ID: 27476975
[TBL] [Abstract][Full Text] [Related]
65. Intrinsic Astrocyte Heterogeneity Influences Tumor Growth in Glioma Mouse Models.
Irvin DM; McNeill RS; Bash RE; Miller CR
Brain Pathol; 2017 Jan; 27(1):36-50. PubMed ID: 26762242
[TBL] [Abstract][Full Text] [Related]
66. Serum exosomes and cytokines promote a T-helper cell type 2 environment in the peripheral blood of glioblastoma patients.
Harshyne LA; Nasca BJ; Kenyon LC; Andrews DW; Hooper DC
Neuro Oncol; 2016 Feb; 18(2):206-15. PubMed ID: 26180083
[TBL] [Abstract][Full Text] [Related]
67. Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis.
Fong MY; Zhou W; Liu L; Alontaga AY; Chandra M; Ashby J; Chow A; O'Connor ST; Li S; Chin AR; Somlo G; Palomares M; Li Z; Tremblay JR; Tsuyada A; Sun G; Reid MA; Wu X; Swiderski P; Ren X; Shi Y; Kong M; Zhong W; Chen Y; Wang SE
Nat Cell Biol; 2015 Feb; 17(2):183-94. PubMed ID: 25621950
[TBL] [Abstract][Full Text] [Related]
68. Single-step isolation of extracellular vesicles by size-exclusion chromatography.
Böing AN; van der Pol E; Grootemaat AE; Coumans FA; Sturk A; Nieuwland R
J Extracell Vesicles; 2014; 3():. PubMed ID: 25279113
[TBL] [Abstract][Full Text] [Related]
69. Fast gapped-read alignment with Bowtie 2.
Langmead B; Salzberg SL
Nat Methods; 2012 Mar; 9(4):357-9. PubMed ID: 22388286
[TBL] [Abstract][Full Text] [Related]
70. Interaction between lung cancer cells and astrocytes via specific inflammatory cytokines in the microenvironment of brain metastasis.
Seike T; Fujita K; Yamakawa Y; Kido MA; Takiguchi S; Teramoto N; Iguchi H; Noda M
Clin Exp Metastasis; 2011 Jan; 28(1):13-25. PubMed ID: 20953899
[TBL] [Abstract][Full Text] [Related]
71. Automated genome annotation and pathway identification using the KEGG Orthology (KO) as a controlled vocabulary.
Mao X; Cai T; Olyarchuk JG; Wei L
Bioinformatics; 2005 Oct; 21(19):3787-93. PubMed ID: 15817693
[TBL] [Abstract][Full Text] [Related]
72. The KEGG resource for deciphering the genome.
Kanehisa M; Goto S; Kawashima S; Okuno Y; Hattori M
Nucleic Acids Res; 2004 Jan; 32(Database issue):D277-80. PubMed ID: 14681412
[TBL] [Abstract][Full Text] [Related]
73. Current pharmacologic treatment of brain metastasis in non-small cell lung cancer.
Okuno T; Isobe T; Tsubata Y
Clin Exp Metastasis; 2024 Mar; ():. PubMed ID: 38466521
[TBL] [Abstract][Full Text] [Related]
74. Clinical Practice Guidelines for Brain Metastasis From Solid Tumors.
Sung KS
Brain Tumor Res Treat; 2024 Jan; 12(1):14-22. PubMed ID: 38317485
[TBL] [Abstract][Full Text] [Related]
75. The clinical outcome and risk factors analysis of immune checkpoint inhibitor-based treatment in lung adenocarcinoma patients with brain metastases.
Zhou J; Wu Y; Xie M; Fang Y; Zhao J; Lee SY; Im Y; Ye L; Su C
Transl Lung Cancer Res; 2022 Apr; 11(4):656-669. PubMed ID: 35529783
[TBL] [Abstract][Full Text] [Related]
76. Immune Checkpoint Inhibitors with or without Radiotherapy in Non-Small Cell Lung Cancer Patients with Brain Metastases: A Systematic Review and Meta-Analysis.
Kim DY; Kim PH; Suh CH; Kim KW; Kim HS
Diagnostics (Basel); 2020 Dec; 10(12):. PubMed ID: 33339421
[TBL] [Abstract][Full Text] [Related]
77. The Current Status of Immune Checkpoint Inhibitors in Neuro-Oncology: A Systematic Review.
Brahm CG; van Linde ME; Enting RH; Schuur M; Otten RHJ; Heymans MW; Verheul HMW; Walenkamp AME
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32143288
[TBL] [Abstract][Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
